by synergycap1 | Mar 23, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Finance, Non-Bank Loans, Working Capital
With Twitter’s advertising business struggling, the company has begun looking at other means of making money. Twitter is exploring a paid subscription-based version of its Tweetdeck app, according to photos posted to Twitter (of course) of a survey the company...
by synergycap1 | Mar 23, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Finance, Working Capital
As expected, the amended version of the House Republican bill to replace the Affordable Care Act would achieve less than half the budgetary savings of the original bill over a decade, with the same coverage losses, the nonpartisan Congressional Budget Office reported...
by synergycap1 | Mar 23, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
(Reuters) – Amazon.com Inc on Thursday won a more than $1.5 billion tax dispute with the Internal Revenue Service over transactions involving a Luxembourg unit more than a decade ago.
by synergycap1 | Mar 23, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Working Capital
Sound Transit reported a significant jump in ridership on the Seattle area’s Link light rail system as uncertainty mounts over regional transit development. Use of the rapid transit system increased 83.8 percent to more than 19 million rides in the past year,...
by synergycap1 | Mar 23, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
WASHINGTON (Reuters) – Saudi Arabia is having “serious discussions” with the New York Stock Exchange about having the NYSE as one of the exchanges for state oil giant Saudi Aramco’s IPO, the Saudi foreign minister told Fox News on...
by synergycap1 | Mar 23, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital
In an uncertain health care market, one biotechnology player stands out to Jim Cramer as a “rare island of calm” that is shaping up to be a prime takeover target: Agilent. With low debt, lots of cash on hand, strong fundamentals, and plenty of overseas...
